VRTX vs. SOL-USD
VRTX (Vertex Pharmaceuticals Incorporated) is a stock, while SOL-USD (Solana) is a cryptocurrency. Over the past 5 years, VRTX returned 18.18%/yr vs 12.17%/yr for SOL-USD. At a 0.06 correlation, their price movements are largely independent.
Performance
VRTX vs. SOL-USD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VRTX achieves a -1.86% return, which is significantly higher than SOL-USD's -44.76% return.
VRTX
- 1D
- -0.03%
- 1M
- -1.22%
- YTD
- -1.86%
- 6M
- -1.57%
- 1Y
- -2.31%
- 3Y*
- 9.16%
- 5Y*
- 18.18%
- 10Y*
- 17.15%
SOL-USD
- 1D
- 0.85%
- 1M
- -25.39%
- YTD
- -44.76%
- 6M
- -48.38%
- 1Y
- -53.76%
- 3Y*
- 68.07%
- 5Y*
- 12.17%
- 10Y*
- —
VRTX vs. SOL-USD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
VRTX Vertex Pharmaceuticals Incorporated | -1.86% | 12.58% | -1.03% | 40.90% | 31.50% | -7.08% | -4.16% |
SOL-USD Solana | -44.76% | -34.09% | 85.68% | 919.96% | -94.13% | 11,143.63% | 81.60% |
Correlation
The correlation between VRTX and SOL-USD is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.04 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.07 |
Correlation (All Time) Calculated using the full available price history since Apr 10, 2020 | 0.06 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VRTX vs. SOL-USD — Risk / Return Rank
VRTX
SOL-USD
VRTX vs. SOL-USD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vertex Pharmaceuticals Incorporated (VRTX) and Solana (SOL-USD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VRTX | SOL-USD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.65 | ||
| Sortino ratioReturn per unit of downside risk | +1.08 | ||
| Omega ratioGain probability vs. loss probability | 1.02 | 0.91 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | -0.14 | -0.72 | +0.58 |
| Martin ratioReturn relative to average drawdown | -0.29 | -1.16 | +0.86 |
Loading charts...
Drawdowns
VRTX vs. SOL-USD - Drawdown Comparison
The maximum VRTX drawdown since its inception was -91.77%, roughly equal to the maximum SOL-USD drawdown of -96.27%. Use the drawdown chart below to compare losses from any high point for VRTX and SOL-USD.
Loading charts...
Drawdown Indicators
| VRTX | SOL-USD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.77% | -96.27% | +4.50% |
Max Drawdown (1Y)Largest decline over 1 year | -23.56% | -74.89% | +51.33% |
Max Drawdown (3Y)Largest decline over 3 years | -29.07% | -76.28% | +47.21% |
Max Drawdown (5Y)Largest decline over 5 years | -29.07% | -96.27% | +67.20% |
Max Drawdown (10Y)Largest decline over 10 years | -41.60% | — | — |
Current DrawdownCurrent decline from peak | -13.90% | -73.76% | +59.86% |
Average DrawdownAverage peak-to-trough decline | -37.73% | -51.42% | +13.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.30% | 53.06% | -41.76% |
Volatility
VRTX vs. SOL-USD - Volatility Comparison
The current volatility for Vertex Pharmaceuticals Incorporated (VRTX) is 7.47%, while Solana (SOL-USD) has a volatility of 17.62%. This indicates that VRTX experiences smaller price fluctuations and is considered to be less risky than SOL-USD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VRTX | SOL-USD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.47% | 17.62% | -10.15% |
Volatility (6M)Calculated over the trailing 6-month period | 20.71% | 46.90% | -26.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 34.13% | 60.08% | -25.95% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.53% | 82.35% | -53.82% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.82% | 99.82% | -67.00% |
Frequently Asked Questions
VRTX and SOL-USD have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SOL-USD has higher volatility (17.62%) compared to VRTX (7.47%). In terms of maximum drawdown, VRTX dropped -91.77% vs SOL-USD's -96.27%.
VRTX currently has the higher Sharpe Ratio (-0.10 vs -0.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VRTX and SOL-USD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer